WOCKHARDT BIO AG FDA Approval ANDA 070755

ANDA 070755

WOCKHARDT BIO AG

FDA Drug Application

Application #070755

Application Sponsors

ANDA 070755WOCKHARDT BIO AG

Marketing Status

Prescription001

Application Products

001SYRUP;ORALEQ 300MG CARBONATE/5ML0LITHIUM CITRATELITHIUM CITRATE

FDA Submissions

ORIG1AP1986-05-21
LABELING; LabelingSUPPL2AP1987-02-17
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1987-03-25
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1987-03-25
LABELING; LabelingSUPPL5AP1989-03-27
LABELING; LabelingSUPPL6AP1990-08-29
LABELING; LabelingSUPPL7AP1994-08-12
LABELING; LabelingSUPPL8AP1996-02-05
LABELING; LabelingSUPPL9AP1997-04-22
LABELING; LabelingSUPPL13AP2008-04-28
LABELING; LabelingSUPPL14AP2022-10-13STANDARD
LABELING; LabelingSUPPL15AP2022-10-13STANDARD

Submissions Property Types

SUPPL3Null0
SUPPL4Null0
SUPPL14Null7
SUPPL15Null7

TE Codes

001PrescriptionAA

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 70755
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.